title: Presenilin-mediated modulation of capacitative calcium entry.
abstract: We studied a novel function of the presenilins (PS1 and PS2) in governing capacitative calcium entry (CCE), a refilling mechanism for depleted intracellular calcium stores. Abrogation of functional PS1, by either knocking out PS1 or expressing inactive PS1, markedly potentiated CCE, suggesting a role for PS1 in the modulation of CCE. In contrast, familial Alzheimer's disease (FAD)-linked mutant PS1 or PS2 significantly attenuated CCE and store depletion-activated currents. While inhibition of CCE selectively increased the amyloidogenic amyloid beta peptide (Abeta42), increased accumulation of the peptide had no effect on CCE. Thus, reduced CCE is most likely an early cellular event leading to increased Abeta42 generation associated with FAD mutant presenilins. Our data indicate that the CCE pathway is a novel therapeutic target for Alzheimer's disease.
authors.affiliation: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Yoo
authors.forename: I
authors.initials: I
authors.lastname: Cheng
authors.forename: S
authors.initials: S
authors.lastname: Chung
authors.forename: T Z
authors.initials: TZ
authors.lastname: Grenfell
authors.forename: H
authors.initials: H
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Pack-Chung
authors.forename: M
authors.initials: M
authors.lastname: Handler
authors.forename: J
authors.initials: J
authors.lastname: Shen
authors.forename: W
authors.initials: W
authors.lastname: Xia
authors.forename: G
authors.initials: G
authors.lastname: Tesco
authors.forename: A J
authors.initials: AJ
authors.lastname: Saunders
authors.forename: K
authors.initials: K
authors.lastname: Ding
authors.forename: M P
authors.initials: MP
authors.lastname: Frosch
authors.forename: R E
authors.initials: RE
authors.lastname: Tanzi
authors.forename: T W
authors.initials: TW
authors.lastname: Kim
mesh_terms: D000544:Alzheimer Disease / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism*; D020746:Calcium Channels, L-Type / Q000187:drug effects / Q000378:metabolism; D020864:Calcium Channels, N-Type / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D015638:Cytochalasin D / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D017136:Ion Transport / Q000187:drug effects / Q000235:genetics; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D016297:Mutagenesis, Site-Directed; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D018408:Patch-Clamp Techniques; D010446:Peptide Fragments / Q000378:metabolism; D053764:Presenilin-1; D053766:Presenilin-2; D014162:Transfection
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D020864:Calcium Channels, N-Type; D007093:Imidazoles; D008565:Membrane Proteins; C508853:PSEN1 protein, human; C508861:PSEN2 protein, human; D010446:Peptide Fragments; D053764:Presenilin-1; D053766:Presenilin-2; C075222:amyloid beta-protein (1-42); D015638:Cytochalasin D; C063159:1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole; D002118:Calcium